BriaCell Therapeutics Corp.
Market Cap
$1.70K
P/E Ratio
—
EPS
—
Dividend Yield
0.00%
52-Week Range
$0.00 — $0.06
Volume
186.08K
Avg Volume
71.38K
Beta
—
P/E (TTM)
—
Forward P/E
—
PEG Ratio
0.03
P/S (TTM)
0.00
P/B (TTM)
0.28
P/FCF
—
EV/EBITDA
—
EV/Sales
—
ROE (TTM)
-2.06%
ROA (TTM)
-1.01%
ROIC
—
Gross Margin
0.00%
Operating Margin
0.00%
Net Margin
—
Debt/Equity
0.00
Current Ratio
10.10
EPS Growth (YoY)
—
Revenue Growth (YoY)
—
EPS Growth (3Y)
-6.05%
EPS Growth (5Y)
-3.46%
Sales Growth (3Y)
+0.00%
Sales Growth (5Y)
+0.00%
EPS Est (This Year)
$0.00
EPS Est (Next Year)
$0.00
Dividend Yield
—
Annual Dividend
—
Payout Ratio
—
Frequency
—
Ex-Dividend Date
—
Cash/Share
$14.45
Institutional %
—
Inst. Net Change
—
Insider Net Shares (90d)
—
Outstanding Shares
1.88M
Float
1.65M
Free Float %
87.64%
Sector
Healthcare
Industry
Biotechnology
Country
CA
Exchange
NASDAQ
IPO Date
2012-08-13
Employees
16
CEO
William V. Williams
Index Membership
—
Website
https://briacell.com
BriaCell Therapeutics Corp. (BCTXW) is a healthcare company in the biotechnology industry listed on the NASDAQ. With a market capitalization of $1.70K, BCTXW is tracked by stockscreenr alongside 25,000+ other tickers. Use the free stock screener to compare BCTXW against other stocks using dozens of fundamental and technical filters.
No, BriaCell Therapeutics Corp. (BCTXW) does not currently pay a regular dividend. The company may be reinvesting profits into growth, research, or debt reduction instead of returning cash to shareholders through dividends.
BriaCell Therapeutics Corp. (BCTXW) has a market capitalization of $1,695, classifying it as a micro-cap company. Market cap is calculated by multiplying the current share price by the total number of outstanding shares.